Tuesday, February 20, 2018

Tuesday, 19 September 2017 Divani Caravel Hotel

Nektarios Tavernarakis

Professor of Molecular Systems Biology, Medical School, University of Crete, Chairman of the Board of Directors at the Foundation for Research and Technology Hellas (FORTH), Research Director, Institute of Molecular Biology and Biotechnology (IMBB)

Nektarios Tavernarakis
Nektarios Tavernarakis

Nektarios Tavernarakis is the Chairman of the Board of Directors at the Foundation for Research and Technology-Hellas (FORTH), Research Director at the Institute of Molecular Biology and Biotechnology (IMBB), and Professor of Molecular Systems Biology at the Medical School of the University of Crete, in Heraklion, Greece. He is the Director of the Graduate Program on BioInformatics at the Medical School of the University of Crete, and is also heading the Neurogenetics and Ageing laboratory of IMBB. He is an elected member of the Scientific Council of the European Research Council (ERC), the European Molecular Biology Organization (EMBO), and Academia Europaea. He has also served as the Director of the Institute of Molecular Biology and Biotechnology. His research focuses on the molecular mechanisms of necrotic cell death and neurodegeneration, the interplay between cellular metabolism and ageing, the mechanisms of sensory transduction and integration by the nervous system, and the development of novel genetic tools for biomedical research. He has received several notable scientific prizes, including an ERC Proof of Concept Grant and two ERC Advanced Investigator Grants. He is also the recipient of the EMBO Young Investigator award, the Alexander von Humboldt Foundation, Friedrich Wilhelm Bessel research award, the Bodossaki Foundation Scientific Prize for Medicine and Biology, the Empeirikeion Foundation Academic Excellence Prize, the Research Excellence award of the Foundation for Research and Technology-Hellas, the BioMedical Research Award of the Academy of Athens, the Galien Scientific Research Award, the Helmholtz International Fellow Award, the International Human Frontier in Science Program Organization (HFSPO) long-term Postdoctoral Fellowship, and the Honorary Education Business Award.

International speakers

Jan Geissler Jan Geissler is founder and managing director of Patvocates, acting as advisor on patient advocacy, health policy and social media. From 2012-2017, he has been the Director of the 'European Patients Academy' (EUPATI), which has developed education about medicines development processes. He is now coordinating the team that takes change of the evolution of EUPATI.
Peter Hohenberger Peter Hohenberger, MD, is Head of the Division of Surgical Oncology and Thoracic Surgery at the Medical Faculty Mannheim, University of Heidelberg (UMM). He is a boarded surgeon in visceral and vascular surgery as well as in thoracic surgery and surgical intensive care.
Panos Kanavos Panos Kanavos (BSc, MSc (Oxon), MSc (LSE), PhD) is Associate Professor in International Health Policy in the Department of Social Policy, London School of Economics (LSE), Deputy Director at LSE Health, and Programme Director of the Medical Technology Research Group (MTRG) at LSE Health.
Annalisa Trama Dr. Annalisa Trama graduated cum laude in Medicine and Surgery from the University of Rome "La Sapienza"(1993-1999). She obtained her Master’s in health services/system research from London School of Hygiene and Tropical Medicine (2001-2002), she specialized in Public Health from University “La Sapienza”– Rome (1999-2003). She obtained her PhD in Public Health from University “La Sapienza”– Rome (2004-2006).

© 2018 Boussias Communications, all rights reserved. info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team